Newline Group
a Lloyd's-market underwriting manager running a dedicated Clinical Trials product line — life-of-trial policies up to ten years, country-specific annual "all trial" policies, and bespoke multi-country or global master difference-in-conditions/difference-in-limits programs.
- Country
- United Kingdom
EU
Coverage
| EU | US | |
|---|---|---|
| insurance-risk | ✓ | ✓ |
Regulatorsfdaema
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Clinical-trial insurance brokerage | insurance-risk | Low | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.